We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Amdocs
DOX
$6.22B
| $84.5M | 0.19% |
1,020,186
-362,813
| -26% | -$29.9M |
|
127
U-Haul Holding Co
UHAL
$14.6B
| $84.4M | 0.19% |
1,812,830
+2,980
| +0.2% | +$154K |
|
128
Hormel Foods
HRL
$13.8B
| $84.3M | 0.19% |
1,779,291
-81,717
| -4% | -$4.08M |
|
129
Olin
OLN
$2.12B
| $84M | 0.19% |
1,844,228
+192,540
| +12% | +$11.1M |
|
130
Zoetis
ZTS
$30B
| $83.7M | 0.19% |
487,940
-220,109
| -31% | -$38.1M |
|
131
Expedia Group
EXPE
$37.3B
| $83.6M | 0.19% |
917,414
+738,265
| +412% | +$105M |
|
132
United Therapeutics
UTHR
$23.1B
| $83.2M | 0.19% |
353,078
-23,313
| -6% | -$4.74M |
|
133
Blackrock
BLK
$176B
| $83.2M | 0.19% |
139,090
-127,685
| -48% | -$83.1M |
|
134
Mettler-Toledo International
MTD
$28.6B
| $83.1M | 0.19% |
73,349
-24,024
| -25% | -$30.2M |
|
135
SLB Ltd
SLB
$75B
| $83M | 0.19% |
2,319,749
+1,338,896
| +137% | +$55.8M |
|
136
Capital One
COF
$134B
| $82.8M | 0.19% |
812,914
-302,909
| -27% | -$37M |
|
137
Global Payments
GPN
$22.8B
| $82.6M | 0.19% |
757,881
+143,051
| +23% | +$18.1M |
|
138
NextEra Energy
NEE
$177B
| $82.5M | 0.19% |
1,078,802
-153,521
| -12% | -$11.7M |
|
139
KLA
KLAC
$259B
| $82.5M | 0.19% |
2,628,270
-1,503,840
| -36% | -$50.6M |
|
140
Reliance Steel & Aluminium
RS
$21.6B
| $81.5M | 0.18% |
488,735
+37,585
| +8% | +$7.02M |
|
141
The Mosaic Company
MOS
$7.33B
| $80.8M | 0.18% |
1,711,762
+839,673
| +96% | +$51.4M |
|
142
Automatic Data Processing
ADP
$108B
| $80.6M | 0.18% |
383,749
-115,266
| -23% | -$25.3M |
|
143
QuidelOrtho
QDEL
$838M
| $80.4M | 0.18% |
828,782
+222,131
| +37% | +$22.6M |
|
144
Halliburton
HAL
$26.6B
| $79.4M | 0.18% |
2,530,750
-119,403
| -5% | -$4.45M |
|
145
Cognizant
CTSH
$26B
| $78.9M | 0.18% |
1,174,990
+444,285
| +61% | +$34M |
|
146
Comcast
CMCSA
$90B
| $78.6M | 0.18% |
2,030,072
+759,228
| +60% | +$32.6M |
|
147
Cigna
CI
$74.6B
| $78.3M | 0.18% |
297,103
-34,421
| -10% | -$8.87M |
|
148
Mondelez International
MDLZ
$79.9B
| $77.6M | 0.18% |
1,253,745
+167,855
| +15% | +$10.6M |
|
149
APA Corp
APA
$13.2B
| $77.5M | 0.18% |
2,220,519
+833,192
| +60% | +$35.4M |
|
150
Simon Property Group
SPG
$72.3B
| $77.4M | 0.17% |
820,817
+278,325
| +51% | +$31.9M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.